Report cover image

The World Liquid Biopsy Market

Published May 30, 2019
Length 210 Pages
SKU # KLI15985953

Description

The World Liquid Biopsy Market

Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer.

This report, The World Liquid Biopsy Market, from Kalorama Information, contains up-to-date information and useful data points for business planning:
  • Research vs. Clinical Liquid Biopsy
  • The Market for Liquid Biopsy by Region
  • The Market for Liquid Biopsy Market by Type of Analyte
  • The Market for CTC-based Liquid Biopsy
  • The Market for ctDNA-based Liquid Biopsy
  • The Market for EV and Exosome-based Liquid Biopsy
  • The Market for Multi-Analyte-based Liquid Biopsy
  • The Market for Other Liquid Biopsy
  • Liquid Biopsy Market by Type of Cancer (Breast, Lung, Colorectal, Ovarian, Prostate, Pan-Cancer, Other Cancer)
  • Selected ctDNA-based Liquid Biopsy Tests in Development
  • Selected Market-Available CTC-based Liquid Biopsy Tests, 2019
  • Selected Liquid Biopsy Tests That Assess Multiple Analytes, 2019
While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they have risks and limitations and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care.

Liquid biopsy testing has many potential applications in aspects of clinical oncology, including:
  • Early detection and diagnosis / screening
  • Alternative testing method when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown
  • Therapy personalization and monitoring – by molecular characterization of a patient’s disease, clinicians can select the optimal course of therapy and monitor efficacy over time, as well as quickly react to adjust therapy should treatment resistance arise
  • Disease monitoring – to observe disease progression, tumor evolution, residual disease, and early detection of recurrence
  • Prognosis of disease

Table of Contents

210 Pages
    • Introduction
    • Liquid Biopsy Technologies
    • Industry Structure
    • Liquid Biopsy Market Revenues and Forecast
    • Introduction
    • Current Major Liquid Biopsy Technologies
    • Introduction
    • Advantages and Limitations of ctDNA in Liquid Biopsy
    • Current ctDNA-based Liquid Biopsy Tests
    • ctDNA-based Liquid Biopsy Tests in Development
    • Introduction
    • Challenges in the Development of CTC-based Liquid Biopsy Tests
    • CTC-based Liquid Biopsy Tests
    • CTC-based Liquid Biopsy Tests in Development
    • Introduction
    • Liquid Biopsy Tests Based on Extracellular Vesicles / Other Analytes
    • Extracellular Vesicle/Other Analyte-based Liquid Biopsy Tests in Development
    • Introduction
    • Liquid Biopsy Tests Based on Multiple Analytes
    • Multiple Analyte-based Liquid Biopsy Tests in Development
    • Introduction
    • Liquid Biopsy Tests for Research Use Only
    • Introduction
    • Tiers of Competition
    • Competitive Factors
    • Significant Market Trends
    • Competitors No Longer in the Liquid Biopsy Market
    • Market Overview
    • Market Forecast
    • Circulating Tumor DNA
    • Circulating Tumor Cells
    • Extracellular Vesicles and Other Analytes
    • Multiple Analytes
    • Therapy Guidance and Monitoring
    • Diagnosis/Screening
    • Disease Prognosis
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Other Cancers
    • Pan-Cancer Tests
    • Top Ten Companies in the Liquid Biopsy Market
    • Adaptive Biotechnologies
    • Agena Bioscience, Inc.
    • ANGLE, plc
    • Biocartis Group NV
    • Biocept, Inc.
    • Biodesix
    • CellMax Life
    • Circulogene
    • DiaCarta, Inc.
    • Epic Sciences
    • Epigenomics AG
    • Exact Sciences
    • Exosome Diagnostics, Inc.
    • Foundation Medicine, Inc.
    • Freenome, Inc.
    • Genomic Health, Inc.
    • GILUPI GmbH
    • GRAIL
    • Guardant Health, Inc.
    • Hologic
    • Inivata
    • Liquid Biotech USA
    • LungLife AI (formerly Cynvenio Biosystems)
    • MDxHealth
    • Menarini-Silicon Biosystems, Spa
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • NeoGenomics Laboratories, Inc.
    • OncoCyte Corporation
    • OncoDNA S.A.
    • Personal Genome Diagnostics
    • QIAGEN N.V.
    • Resolution Biosciences
    • Roche Diagnostics
    • Sysmex-Inostics, Inc.
    • Tempus
    • Vermillion, Inc.
    • VolitionRx
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.